Rejection of subcutaneous tumors and control of a subset of orthotopic pancreatic tumors was correlated to the degree of tumor-specific T cell expansion following implantation and providing DC maturation signals via CD40 at the time of tumor implantation prevented orthotopic pancreatic tumor growth53. The gene discussed is CD40; the disease is neoplasm.